Relafen and Yasmin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relafen (nabumetone) and Yasmin (drospirenone; ethinyl estradiol). Common drug interactions include injury among females.

The phase IV clinical study analyzes what interactions people have when they take Relafen and Yasmin. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Relafen?

Relafen has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 6,243 Relafen users. Check the latest studies of Relafen.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

On Jul, 21, 2026

59 people who take Relafen and Yasmin together, and have interactions are studied.

What are the common drug interactions of Relafen and Yasmin, by gender? *:

female:

Injury
Pulmonary embolism (blockage of the main artery of the lung)
Abdominal pain upper
Pain in extremity
Contusion (a type of hematoma of tissue in which capillaries)
Loss of consciousness
Biliary colic
Blindness
Cholecystitis acute (rapid infection of gallbladder)
Ear pain

male:

n/a

What are the common drug interactions of Relafen and Yasmin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Injury
Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Back pain
Blood testosterone decreased
Cholecystitis chronic (long lasting infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Drug ineffective
Emotional distress
Fear

20-29:

Biliary colic
Cholecystitis acute (rapid infection of gallbladder)
Cholecystitis chronic (long lasting infection of gallbladder)
Epigastric discomfort
Post cholecystectomy syndrome
Upper respiratory tract infection
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Anxiety
Injury
Pulmonary embolism (blockage of the main artery of the lung)

30-39:

Acute myocardial infarction (acute heart attack)
Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
Cholecystitis chronic (long lasting infection of gallbladder)
Cholesterosis (abnormal deposition of cholesterol in tissues)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Gallbladder disorder
Injury
Syncope (loss of consciousness with an inability to maintain postural tone)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety

40-49:

Pulmonary embolism (blockage of the main artery of the lung)
Injury
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Abdominal pain
Cholecystitis chronic (long lasting infection of gallbladder)
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)
Anxiety
Atelectasis (partial or complete collapse of the lung)
Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)

50-59:

Anxiety
Blindness
General physical health deterioration (weak health status)
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Injury
Laceration (tearing of soft body tissue)
Loss of consciousness
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Muscle spasms (muscle contraction)

60+:

n/a

What are the existing conditions these people have? *

Premenstrual Syndrome: 13 people, 22.03%
Pain: 12 people, 20.34%
Menstruation Irregular: 7 people, 11.86%
Stress And Anxiety: 6 people, 10.17%
Menstrual Disorder (disease of menstrual cycle): 6 people, 10.17%
Acne (skin problems that cause pimples): 6 people, 10.17%
Upper Respiratory Tract Infection: 5 people, 8.47%
Depression: 5 people, 8.47%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 6.78%
Heavy Or Prolong Menstrual Bleeding: 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Relafen and Yasmin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously